Understanding oliguria in the critically ill.
Clinical Department and Laboratory of Intensive Care Medicine, Division of Cellular and Molecular Medicine, KU Leuven University, Herestraat 49, B3000, Louvain, Belgium. marie.schetz@uzleuven.be.
Miet
http://orcid.org/0000-0001-5776-4827
M
Schetz
Intensive Care Unit, Ghent University Hospital, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.|Research Foundation-Flanders (FWO), Egmontstraat 5, 1000, Brussels, Belgium.
Eric
E
Hoste
D058186:Acute Kidney Injury / Q000097:blood / Q000652:urine; D015415:Biomarkers / Q000097:blood / Q000652:urine; D003404:Creatinine / Q000097:blood; D016638:Critical Illness; D003937:Diagnosis, Differential; D004232:Diuretics / Q000627:therapeutic use; D005440:Fluid Therapy / Q000009:adverse effects; D005919:Glomerular Filtration Rate; D006801:Humans; D007362:Intensive Care Units; D009846:Oliguria / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D012079:Renal Circulation; D017582:Renal Replacement Therapy; D012720:Severity of Illness Index; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D015415:Biomarkers; D004232:Diuretics; D014662:Vasoconstrictor Agents; D003404:Creatinine